DOTMV·shop.mvrent.mvEN
Explore
MedicinePOM

INFLUVAC TETRA 2024

Generic: Influenza Vaccine ( Trivalent / Quadrivalent)

Parenteral ( Injection- Suspension) · 15µg HA* + 15µg HA* + 15µg HA* + 15µg HA* (0.5ml syringe)

Dosage form
Parenteral ( Injection- Suspension)
Strength
15µg HA* + 15µg HA* + 15µg HA* + 15µg HA* (0.5ml syringe)
Manufacturer
Abbott Biologicals B.V., Veerweg 12, 8121 AA, Olst, Netherlands
Product no.
P5914
Valid from
27.02.2024
Valid to
26.02.2027
Pre-auth required
No

Other brands under Influenza Vaccine ( Trivalent / Quadrivalent)

These brands contain the same active ingredient and are therapeutic equivalents.

Brand nameDosage formStrengthImporterCategory
Influenza Vaccine ( Trivalent / Quadrivalent)Parenteral ( Injection )Strains are changed on seasonal basis—POM
Influvac®Parenteral ( Injection )15mcg + 15mcg + 15mcg +15mcgState Trading Organization PlcPOM
INFLUVAC 2025/2026Parenteral ( Injection )0.5ml—POM
Influvac® TetraParenteral ( Injection )15mcg + 15mcg + 15mcg +15mcgState Trading Organization PlcPOM
INFLUVAC TETRA 2024/2025Parenteral ( Injection )15µg HA* + 15µg HA* + 15µg HA* + 15µg HA* (0.5ml syringe)—POM
INFLUVAC TETRA 2025Parenteral ( Injection- Suspension)15µg HA* + 15µg HA* + 15µg HA* + 15µg HA* (0.5ml syringe)—POM
Old search API